http://orcid.org/0000-0003-3298-1125
Figures
Abstract
Background
Screening with faecal occult blood tests reduces colorectal cancer-related mortality; however, age, sex and socioeconomic factors affect screening outcomes and could lead to unequal mortality benefits. The aim of this study was to describe the main outcomes of the population-based Barcelona colorectal cancer screening programme (BCRCSP) by deprivation.
Methods
Retrospective study of the eligible population of the first round of the BCRCSP. Participants’ postal addresses were linked with the MEDEA database to obtain the deprivation quintiles (Dq). Chi-squared tests were used to compare proportions across variables and logistic regression was used to estimate the adjusted effects of age, sex and deprivation on uptake, FIT positivity, colonoscopy adherence and advanced neoplasia detection rate.
Results
Overall uptake was 44.7%, higher in Dq2, 3 and 4 (OR 1.251, 1.250 and 1.276, respectively) than in the least deprived quintile (Dq 1), and lowest in Dq5 (OR 0.84). Faecal immunochemical test (FIT) positivity and the percentage of people with detectable faecal haemoglobin below the positivity threshold increased with deprivation. The advanced neoplasia detection rate was highest in Dq4.
Conclusion
Unlike most regions where inequalities are graded along the socioeconomic continuum, inequalities in the uptake of colorectal cancer screening in Spain seem to be concentrated first in the most disadvantaged group and second in the least deprived group. The correlation of deprivation with FIT-positivity and faecal haemoglobin below the positivity threshold is worrying due to its association with colorectal cancer and overall mortality.
Citation: Buron A, Auge JM, Sala M, Román M, Castells A, Macià F, et al. (2017) Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people. PLoS ONE 12(6): e0179864. https://doi.org/10.1371/journal.pone.0179864
Editor: Ajay Goel, Baylor University Medical Center, UNITED STATES
Received: March 17, 2017; Accepted: June 5, 2017; Published: June 16, 2017
Copyright: © 2017 Buron et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Due to legal and ethical restrictions, the dataset cannot be made publicly available. All interested readers can send data requests to Isabel Tora (TORA@clinic.cat) or Cristina Hernández (chernandez@parcdesalutmar.cat).
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Colorectal cancer (CRC) is the malignancy with the highest incidence in Spain and is the second leading cause of cancer-related mortality in both sexes [1]. Screening by means of the guaiac-based faecal occult blood test (FOBT) reduces CRC-related mortality [2]. Faecal immunochemical tests (FIT) have recently been demonstrated to be more effective than guaiac-based FOBT, due to both a higher uptake and a higher detection rate of advanced neoplasia [3], and have been associated with a significant reduction in CRC incidence [4] and mortality [5].
To be effective and efficient, population-based screening programmes must achieve strong adherence, and thus high uptake rates in screening and equity in access are critical in any organised programme [6]. However, there is considerable evidence of substantial variation in uptake by age, gender, socioeconomic status and ethnicity in different regions [7–15]. Besides uptake, other screening outcomes vary depending on these variables. Faecal haemoglobin concentrations (f-Hb), and therefore positivity rates, are significantly higher in men and increase with age and greater deprivation [9,13,16,17], among other factors. The positive predictive value of FIT for neoplasia and advanced neoplasia has been reported to be higher for men and older persons, but its association with deprivation is not yet clear [9,18]. If maintained, these differences could lead to unequal mortality reductions.
The aim of this study was to describe the distribution of the main outcomes of the first round of a population-based colorectal cancer screening programme by socioeconomic level, taking into account age and sex.
Materials and methods
Study setting and population
The Barcelona colorectal cancer screening programme (BCRCSP) started in December 2009 and is currently running its fourth round. The programme follows the European Guidelines[6], is entirely free of charge and biennially invites men and women aged 50 to 69 years to a FIT test (OC-Sensor, Eiken Chemical Co. Ltd, Tokyo, Japan; cut-off point set at 100ng haemoglobin [Hb]/mL buffer, equivalent to 20μg Hb/g faeces). Pharmacies serve as the FIT collection point. The results of the first round of the BCRCSP and the screening process have been published in more detail elsewhere [19].
The eligible population of the first round of the BCRCSP comprised 183,187 men and women aged 50 to 69 years who were invited to participate between 12.01.2009 and 12.31.2011. People without socioeconomic data were excluded (10,225, 5.6%), yielding a final study population of 172,962 persons.
Variables and data source
Basic sociodemographic data (age, sex and postal address) and variables related to the screening process (e.g. date of invitation, exclusion category, test result) were drawn from the BCRCSP data system. The Public Health Agency of Barcelona provided the scale known as the Medea deprivation index, based on the results of the Medea Project [20]. This composite deprivation index was created on the basis of five indicators from the 2001 census: unemployment, manual occupation, casual employment, insufficient education (total) and insufficient education among young people (16 to 29 years old). For the city of Barcelona, the index ranges from -1.92 (least deprived) to 4.34 (most deprived). Five groups were constructed on the basis of the census tract quintiles of the city (deprivation quintiles, Dq), where 1 corresponds to the least deprived quintile and 5 to the most deprived quintile. Each person in the study population was assigned a deprivation index value and its corresponding Dq by linking that person’s postal address with the BCRCSP database. There were no differences in the age and sex distribution of the excluded and eligible populations. The sensitivity analysis comprising excluded persons in the models did not modify any of the results.
Definitions
Screened (participants): Those who returned the test and the laboratory provided a valid result.
Uptake: the number of participants divided by the eligible study population (%).
FIT positivity rate: the number of people with a FIT-positive result divided by those screened (%).
Colonoscopy adherence rate: the number of persons undergoing colonoscopy divided by persons with a positive FIT result (%).
Advanced neoplasia: Those with a colonoscopy result indicating medium- and high-risk adenoma or cancer, expressed as a percentage of all colonoscopy results (positive predictive value [PPV] for advanced neoplasia) and as a detection rate (per 1000 participants).
Statistical analyses
A descriptive analysis was conducted for all variables by outcomes. The adjusted effects of age, sex and deprivation on uptake, FIT positivity, colonoscopy adherence and advanced neoplasia detection rates were analysed using logistic regression models. Linear P for trends were tested for categorised age data and deprivation quintiles. P values less than 0.05 were considered statistically significant using a 2-sided test. Analyses were performed using SPSS, version 22.0.
Ethical considerations
The study followed the principles embodied in the Declaration of Helsinki and approval was obtained from the Clinical Research Ethical Committee of the Parc de Salut Mar in July 2014. All databases were anonymised; addresses were erased after linkage to obtain the Medea deprivation index.
Results
Mean age of the eligible population was 58.3 years (SD 5.7). Overall uptake by the study population was 44.7% and was higher among women and persons aged 60–64 years (Table 1). In both sexes, uptake was lowest in the most deprived Dq (33.4% in men, 42.1% in women), followed by the least deprived Dq (38.8% in men, 44.4% in women) and was highest in the intermediate Dq. This pattern of uptake by socioeconomic level was consistent in all age groups among men and women (Fig 1). The absolute difference between the uptake rates in the most deprived group and the intermediate groups was greater in men and in the younger age categories. After adjustment by age and sex, the uptake rate was significantly lower in Dq 5 than in Dq 1 (OR 0.84, 95% CI 0.81–0.86), and the odds of participating were highest in Dqs 2, 3 and 4 (Table 2).
A total of 4,764 people had a positive FIT result (6.2%). As expected, FIT positivity rates were higher in men than in women and increased with age (p-trend<0.001) and deprivation (p-trend<0.001), both in men (7.3% in Dq 1, 8.5% in Dq 5) and in women (4.1% and 5.9%, respectively) (Tables 1 and 2). Table 3 shows the distribution of f-Hb percentiles for all participants and for men and women by deprivation categories. Undetectable f-Hb was found in 55.2% of the participants. As expected, all percentiles were higher in men than in women. The 90%, 95% and 97.5% percentiles for f-Hb consistently increased with Dq in both sexes. The distribution of f-Hb concentration among deprivation categories is shown in Fig 2. Of note, the proportion of people with undetectable f-Hb decreased with deprivation in both sexes, whereas the proportion of people with detectable f-Hb below the threshold of 100ng Hb/mL buffer (i.e. f-Hb between 1 and 99ng Hb/mL buffer) increased with deprivation.
Percentage out of all faecal immunological test (FIT) results within each deprivation group.
Overall colonoscopy adherence was 84.0% and was higher in Dq 3 and 4, with no significant differences for the remaining categories or variables in the adjusted models (Tables 1 and 3). Advanced neoplasia was diagnosed in 1,893 people (PPV 47.3% out of all colonoscopies), yielding an overall detection rate of 24.5 per 1000 participants. The PPV, detection rates, and odds of being diagnosed with an advanced neoplasia were significantly higher in men and increased with age. PPV was lowest for women in Dq 5 and, after adjustment, those in Dq 4 had a statistically significant higher odds of being diagnosed with advanced neoplasia.
Discussion
The results of this study show that socioeconomic deprivation has a significant impact at all stages of the FIT-based colorectal cancer screening pathway. Inequalities in the uptake of CRC screening seem to be concentrated first in the most disadvantaged group and second in the least deprived group. Groups with the greatest deprivation have also the lowest uptake rates, highest positivity rates and lowest detection rates.
Uptake
Uptake was lowest in the most deprived quintile, followed by the least deprived one, and was highest in the intermediate groups. Unlike our results, most studies found a linear reverse association between uptake and deprivation, i.e. the higher the deprivation level the lower the uptake [7–13,15,21]. When interpreting these results, it is important to consider the invitation strategy. In a study performed in Italy, where FOBT test kits are also distributed by pharmacies, high educational attainment and working in a non-manual occupation were positively associated with uptake [21]. In countries where tests are sent by surface mail, such as England, Scotland, Australia and more recently Denmark, uptake consistently decreases with increasing socioeconomic deprivation [7,10,11,18]. Discrepant results have been reported from countries where screening is based on the primary care network: in the Basque Country in Spain, lower uptake rates were found for the most and least deprived groups [14]; in Canada, a correlation was described between higher education and lower uptake [22], and in France the association between uptake and deprivation was contradictory [15]. In the light of these results, there is no apparent association between invitation strategy and patterns of uptake and deprivation.
A worrisome finding was that men in the most deprived groups had the lowest participation rates for FOBT screening, since the incidence of CRC has been shown also to be higher in this group [1,23]. The reasons described for non-participation among the most deprived groups are a lack of information, prioritisation of other problems, not understanding the written information provided, underestimation of the benefits of screening and stronger fears and fatalistic attitudes [24,25]. While insurance status has been described in other contexts to influence CRC screening uptake [15], in Spain health care access is guaranteed for all residents regardless of their socioeconomic level and the BCRCSP is completely free of charge throughout the whole process including all screening and diagnostic tests as well as cancer treatment. Hence, lack of private health insurance among the most deprived is not expected to play a role in the present setting.
Lower screening uptake rates in men have been related to their lesser interest in their health as well as their fear of the diagnostic test, while women may assume the role of caregiver and worry more about their health for the sake of those around them [8,14,26]. On the other hand, the low uptake found in this study among the least deprived persons might be due to their greater access to private healthcare [27], which may offer colonoscopy as an opportunistic screening test [14,22], but this possibility requires confirmation. Therefore, interventions to increase CRC awareness and prevention should, at least initially, target both the most and the least deprived groups.
FIT results
As in previous studies [9,14,16,18], in our study male gender, increasing age and lower socioeconomic status were significantly associated with higher FOBT positivity and f-Hb concentrations. Besides differences in the prevalence of neoplastic lesions, other factors possibly related to these findings are differences in the haemoglobin blood concentration, diet, intestinal transit time and other concomitant comorbidities [9,28]. The sex-independent relationship between deprivation and f-Hb concentrations points towards non–gender-related mechanisms [16] and could be associated with the relationship between deprivation and colorectal cancer incidence, particularly in men [23,29]. Of note, among persons testing negative, the proportion of individuals with detectable f-Hb below the positivity threshold increased with deprivation. To the best of our knowledge, this correlation has not been previously reported per se and is of particular interest because even small values of f-HB have been related not only with CRC-specific mortality but also with overall mortality, therefore suggesting f-HB as a possible marker for mortality [30].
Colonoscopy adherence
Colonoscopy adherence was lower among people in the most deprived groups. A negative association between deprivation and colonoscopy uptake after a positive FOBT has been reported in Scotland [10] and England [9,31], but other authors have found no correlation [11,14]. The lower adherence among the most deprived groups is worrying because of their higher CRC incidence and more restricted access to alternative sources of healthcare. Overall health is a facet of deprivation and hence more deprived individuals may be less likely to be as fit to undergo a colonoscopy than less deprived individuals [9]. Colonoscopy uptake was also lowest among the least deprived women (less so among men), which could also be related to greater access to private colonoscopy [27].
Colonoscopy outcomes
Individuals belonging to the fourth most deprived group had a slightly increased risk of being diagnosed with advanced neoplasia. However, caution must be exercised when interpreting these results, since the sample size is small and the results are constrained both by test positivity and by colonoscopy adherence. PPV values were significantly higher for men, an observation which has already been described before and is probably related to a higher burden of disease [9,10]. Furthermore, we found a lower PPV among the most deprived women, which could point towards a higher false positive rate or lower colonoscopy adherence among deprived women with advanced neoplasia. Other authors have found an association between a higher PPV and higher cancer detection rates with increasing deprivation in both sexes and across all age groups [9].
Strengths and limitations
This study has a large sample size including the eligible population of the first round of an ongoing population-based CRC screening programme. The use of information collected directly from the BCRCSP database ensured a high reliability of the data, avoiding the common selection bias observed in designs using self-administered questionnaires to assess screening and socioeconomic status. Moreover, the present study was able to examine in detail the different outcomes of the programme and, unlike many publications, to report differences in f-Hb concentrations by age, sex and deprivation level.
Nevertheless, the study also has several limitations. The use of an ecological deprivation index to assign individual socioeconomic level may lead to misclassification in some cases. However, many studies rely on similar indicators calculated in small areas [12,16]. Furthermore, studies using individual socioeconomic measures have obtained very similar associations between deprivation and uptake [7]. Another limitation is the time lag between calculation of the deprivation index (2001) and the start of the first round of the programme (2009). Census data in Spain is gathered every 10 years and, unfortunately, data from 2011 could not be used because from that year onwards the census in Spain ceased to be universal and started to be calculated on the basis of a representative 12% sample [32], hindering the use of indicators in small geographical areas, as in this study.
We had no access to information on ethnicity or race, country of origin or nationality. Previous studies have found that ethnic differences were almost completely explained by differences in socioeconomic factors [7]. In the city of Barcelona, many–but not all–of the neighbourhoods classified as being of low socioeconomic level also have the highest share of immigrants [33]. Lastly, the present study was not able to assess the reasons for non-participation or the personal history and colorectal outcomes of persons choosing not to participate and those testing negative.
Conclusions
In Spain, inequalities in the uptake of CRC screening seem to be concentrated first in the most disadvantaged group and second in the least deprived group. Efforts should be made to ensure that equal access is ensured throughout the screening process, minimising inequalities in both uptake and colonoscopy adherence. The relationship between detectable f-Hb and deprivation throughout the spectrum of persons with a negative result is worrying because of its relationship with overall mortality and warrants further investigations.
Our results add to the evidence that there are substantial socioeconomic inequalities, affecting not only uptake and compliance with the diagnostic test, but also test performance. If these differences remain, some groups may derive a disproportionately lower share of the survival benefits of screening, which would inevitably increase the relative socioeconomic inequalities in the incidence of CRC and its associated mortality.
Acknowledgments
Authors would like to thank Ms Cristina Hernández for her support in the data linkage to obtain the deprivation index. PROCOLON is the research group of the Barcelona colorectal cancer screening programme, and currently includes the following members: Jaume Grau (current coordinator, jgrau@clinic.cat; Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain), Rafael Abós-Herrándiz (Carles I Primary Health Care Center, Barcelona, Spain), Eva Abril (Rio de Janeiro Primary Health Care Center, Barcelona, Spain), Marta Aldea (Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain), Cristina Álvarez (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Marco Antonio Álvarez (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Montserrat Andreu (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Isis Araujo (Gastroenterology Department, Endoscopy Unit, ICMDiM, Hospital Clinic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Josep M. Augé (Biochemistry Department, Hospital Clínic de Barcelona, Barcelona, Spain), Anna Aymar (Department of Clinical Epidemiology and Public Health, Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), Barcelona, Spain), Guillermo Bagaria (Official College of Pharmacists of Barcelona (COFB), Barcelona, Spain), Francesc Balaguer (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Xavier Bessa (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Montserrat Bonilla (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain), Andrea Burón (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain), Sabela Carballal (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Antoni Castells (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Xavier Castells (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain), Mercè Comas (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain), Rosa Costa (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Míriam Cuatrecasas (Pathology Department, Hospital Clínic, Barcelona, Spain), Josep M. Dedeu (Department of Gastroenterology, Hospital del Mar, UAB, Parc de Salut Mar, Barcelona, Spain), Maria Estrada (Official College of Pharmacists of Barcelona (COFB), Barcelona, Spain), Imma Garrell (Comte Borrell Primary Health Care Center, Barcelona, Spain), Rafael Guayta (Official College of Pharmacists of Barcelona (COFB), Barcelona, Spain), Jordi Gordillo (Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain), Cristina Hernández (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain), Mar Iglesias (Pathology Department, Hospital del Mar, Barcelona, Spain), María López-Cerón (Gastroenterology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain), Laura Llovet (Liver Unit, Hospital Clinic, CIBEREHD and IDIBAPS, University of Barcelona, Barcelona, Spain), Francesc Macià (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain), Leticia Moreira (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Lorena Moreno (Department of Gastroenterology, Hospital Clínic de Barcelona; Fundació Clínic per la recerca biomèdica, Barcelona, Spain), M. Francisca Murciano (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Gemma Navarro (Pathology Department, Hospital del Mar, Barcelona, Spain), Teresa Ocaña (Gastroenterology Department, Hospital Clínic, Barcelona, Spain), Maria Pellisé (Gastroenterology Department, Hospital Clínic, Barcelona, Spain), Mercè Pintanell (Casc Antic Primary Health Care Center, Barcelona, Spain), Àngels Pozo (Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain), Teresa Puig (Department of Clinical Epidemiology and Public Health, Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), Barcelona, Spain), Faust Riu (Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain), Liseth Rivero-Sánchez (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain), Cristina Rodríguez (Official College of Pharmacists of Barcelona (COFB), Barcelona, Spain), Maria Sala (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain), Ariadna Sánchez (Department of Gastroenterology, Hospital Clínic de Barcelona; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain), Agustín Seoane (Gastroenterology Department, Hospital del Mar, Barcelona, Spain), Anna Serradesanferm (Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain), Judit Sivilla (Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain), Antoni Trilla (Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Hospital Clínic-Universitat de Barcelona-ISGlobal, Barcelona, Spain), Isabel Torà (Preventive Medicine and Hospital Epidemiology Department, Hospital Clínic de Barcelona, Barcelona, Spain).
Author Contributions
- Conceptualization: AB JMA XC MS AC CG.
- Data curation: AB MR MC XB.
- Formal analysis: AB MR MC.
- Investigation: AB CG FM.
- Methodology: AB MR MC JMA.
- Project administration: AB XC MS.
- Resources: FM AC XC.
- Software: MC MR.
- Supervision: XC AC FM AB.
- Validation: AB JMA XC AC FM.
- Visualization: AB.
- Writing – original draft: AB XC.
- Writing – review & editing: JMA MS MR AC FM MC CG XB XC.
References
- 1. IARC. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Colorectal cancer [Internet]. [cited 27 Jun 2014]. Available: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal
- 2. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103: 1541–1549. pmid:18479499
- 3. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JCIY, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59: 62–68. pmid:19671542
- 4. Ventura L, Mantellini P, Grazzini G, Castiglione G, Buzzoni C, Rubeca T, et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2014;46: 82–86. pmid:24011791
- 5. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2015;64: 784–790. pmid:25179811
- 6.
European Commission, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1. ed. Segnan N, Patnick J, Karsa L von, editors. Luxembourg: Office for Official Publications of the European Communities; 2010.
- 7. Frederiksen BL, Jørgensen T, Brasso K, Holten I, Osler M. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer. 2010;103: 1496–1501. pmid:20959827
- 8. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40: 712–718. pmid:21330344
- 9. Mansouri D, McMillan DC, Grant Y, Crighton EM, Horgan PG. The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PloS One. 2013;8: e66063. pmid:23776606
- 10. Steele RJC, Kostourou I, McClements P, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen. 2010;17: 68–74. pmid:20660434
- 11. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut. 2012;61: 101–107. pmid:21561880
- 12. Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 2010;64: 318–324. pmid:19740776
- 13. Ward PR, Javanparast S, Matt MA, Martini A, Tsourtos G, Cole S, et al. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health. 2011;35: 61–65. pmid:21299702
- 14. Hurtado JL, Bacigalupe A, Calvo M, Esnaola S, Mendizabal N, Portillo I, et al. Social inequalities in a population based colorectal cancer screening programme in the Basque Country. BMC Public Health. 2015;15: 1021. pmid:26438240
- 15. Poncet F, Delafosse P, Seigneurin A, Exbrayat C, Colonna M. Determinants of participation in organized colorectal cancer screening in Isère (France). Clin Res Hepatol Gastroenterol. 2013;37: 193–199. pmid:22704817
- 16. Digby J, McDonald PJ, Strachan JA, Libby G, Steele RJC, Fraser CG. Deprivation and faecal haemoglobin: implications for bowel cancer screening. J Med Screen. 2014;21: 95–97. pmid:24803480
- 17. McDonald PJ, Strachan JA, Digby J, Steele RJC, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med. 2012;50: 935–940. pmid:22149740
- 18. Symonds EL, Osborne JM, Cole SR, Bampton PA, Fraser RJ, Young GP. Factors affecting faecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables. J Med Screen. 2015; pmid:25977374
- 19. Burón A, Grau J, Andreu M, Augé JM, Guayta-Escolies R, Barau M, et al. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies]. Med Clínica. 2015;145: 141–146. pmid:25073826
- 20. Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarín MI, et al. [Constructing a deprivation index based on census data in large Spanish cities(the MEDEA project)]. Gac Sanit. 2008;22: 179–187.
- 21. Parente F, Marino B, DeVecchi N, Moretti R, Lecco Colorectal Cancer Screening Group, Ucci G, et al. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg. 2009;96: 533–540. pmid:19358181
- 22. Crouse A, Sadrzadeh SMH, de Koning L, Naugler C. Sociodemographic correlates of fecal immunotesting for colorectal cancer screening. Clin Biochem. 2015;48: 105–109. pmid:25500418
- 23. Rowan S. Trends in cancer incidence by deprivation, England and Wales, 1990–2002. Health Stat Q Off Natl Stat. 2007; 24–35.
- 24. Solmi F, Von Wagner C, Kobayashi LC, Raine R, Wardle J, Morris S. Decomposing socio-economic inequality in colorectal cancer screening uptake in England. Soc Sci Med 1982. 2015;134: 76–86. pmid:25917138
- 25. Gimeno García AZ. Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract. 2012;2012: 483417. pmid:22190913
- 26. Molina-Barceló A, Salas Trejo D, Peiró-Pérez R, Málaga López A. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes. Eur J Cancer Care (Engl). 2011;20: 669–678. pmid:21771129
- 27.
Population with dual healthcare coverage. Catalan Health System Observatory. Generalitat de Catalunya [Internet]. [cited 7 Apr 2016]. Available: http://observatorisalut.gencat.cat/en/detalls/article/06_IND_poblacio_doble_cobertura_sanitaria-00002
- 28. Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol. 2010;105: 2457–2464. pmid:20700114
- 29. Oliphant R, Brewster DH, Morrison DS. The changing association between socioeconomic circumstances and the incidence of colorectal cancer: a population-based study. Br J Cancer. 2011;104: 1791–1796. pmid:21559020
- 30. Chen L-S, Yen AM-F, Fraser CG, Chiu SY-H, Fann JC-Y, Wang P-E, et al. Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. BMJ Open. 2013;3: e003740. pmid:24202058
- 31. Morris S, Baio G, Kendall E, von Wagner C, Wardle J, Atkin W, et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer. 2012;107: 765–771. pmid:22864455
- 32.
Instituto Nacional de Estadistica. Censos de Población y Viviendas 2011: Metodologia [Internet]. [cited 18 Feb 2016]. Available: http://www.ine.es/censos2011_datos/cen11_datos_metodologia.htm
- 33.
Profile of the foreign population in Barcelona. 2014–2015 [Internet]. [cited 7 Apr 2016]. Available: http://www.bcn.cat/estadistica/angles/dades/inf/pobest/pobest15/part1/t43.htm